Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4680030 Target Snapshot

Aspartyl/asparaginyl beta-hydroxylase · SINGLE PROTEIN · Homo sapiens

39Compounds
11Assays
4Approved Drugs
70.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q12797. Use UniProt Q12797 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q12797 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Aspartyl/asparaginyl beta-hydroxylase as ChEMBL target CHEMBL4680030, mapped to UniProt Q12797. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Aspartyl/asparaginyl beta-hydroxylase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL4680030
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q12797
Aspartyl/asparaginyl beta-hydroxylase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Aspartyl/asparaginyl beta-hydroxylase is the right protein anchor across sources, using UniProt Q12797 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAspartyl/asparaginyl beta-hydroxylase
UniProt AccessionQ12797
Component TypeProtein
Sequence Length758 aa

Aspartyl/asparaginyl beta-hydroxylase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Aspartyl/asparaginyl beta-hydroxylase, mapped to UniProt Q12797. Sequence length is 758 aa.

Mapped IDQ12797
Review nameAspartyl/asparaginyl beta-hydroxylase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

4
Approved
2
Phase III
1
Phase I
Assay Mix

Activity Type Distribution

IC5069.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL316034 7.7 IC50 20.0 Preclinical
CHEMBL5422782 7.3 IC50 50.0 Preclinical
CHEMBL5430087 6.96 IC50 110.0 Preclinical
CHEMBL3752910 6.64 Kd 227.22 Preclinical
CHEMBL51483 6.6 IC50 250.0 Clinical
CHEMBL5429223 6.55 IC50 280.0 Preclinical
CHEMBL5425339 6.3 IC50 500.0 Preclinical
CHEMBL5415306 6.24 IC50 580.0 Preclinical
CHEMBL443684 6.1 IC50 800.0 Clinical
CHEMBL5428941 6.05 IC50 900.0 Preclinical
Distribution

pChEMBL Value Distribution

18
5.0
18
5.5
5
6.0
6
6.5
2
7.0
3
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

11
Total Assays
36
Tested Compounds
1
Assay Types
Binding — 11 assays, 36 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 7 22 5.7
single protein format 3 4 6.6
cell-based format 1 10 5.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine